P-L Kellokumpu-Lehtinen

Effect of exercise on bone structural traits, physical performance and body composition in breast cancer patients--a 12-month RCT.

Riku Nikander, Harri Sievänen, Katriina Ojala et al. · PubMed · 2012 · 35 citations

Medicine, Oncology, Rehabilitation Medicine +17

Abstract S1-05: Tumor infiltrating lymphocytes (TILs) indicate trastuzumab benefit in early-stage HER2-positive breast cancer (HER2+ BC)

Sherene Loi, Stefan Michiels, Roberto Salgado et al. · Cancer Research · 2013 · 33 citations

Medicine, Immunology, Oncology +17

Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial

P-L Kellokumpu-Lehtinen, Marie Hjälm-Eriksson, Camilla Thellenberg‐Karlsson et al. · Prostate Cancer and Prostatic Diseases · 2012 · 27 citations

Medicine, Oncology, Radiation Oncology +17

Abstract S4-1: FinXX Final 5-Year Analysis: Results of the Randomised, Open-Label, Phase III Trial in Medium-to-High Risk Early Breast Cancer

Heikki Joensuu, P-L Kellokumpu-Lehtinen, Riikka Huovinen et al. · Cancer Research · 2010 · 14 citations

Medicine, Oncology, Pharmacology +16

Abstract GS3-04: A randomized phase III study of adjuvant trastuzumab for a duration of 9 weeks versus 1 year, combined with adjuvant taxane-anthracycline chemotherapy, for early HER2-positive breast cancer (the SOLD study)

Heikki Joensuu, Jennifer A. Fraser, Hans Wildiers et al. · Cancer Research · 2018 · 12 citations

Medicine, Oncology, Pharmacology +17